Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space.

作者: Eelke van der Horst , Julio E. Peironcely , Gerard J. P. van Westen , Olaf O. van den Hoven , Warren R. J. D. Galloway

DOI: 10.2174/156802611796391230

关键词:

摘要: Chemogenomic approaches, which link ligand chemistry to bioactivity against targets (and, by extension, phenotypes) are becoming more and important due the increasing number of data available both in proprietary databases as well public domain. In this article we review chemogenomics approaches applied four different domains: Firstly, relationship between protein from an approximate relation their respective bioactive ligands can be inferred, investigate extent receptor deorphanization. case it was found that using knowledge about active compounds related proteins, 93% all cases enrichment better than random could obtained. Secondly, analyze chemin-formatics analysis methods with respect behavior studies, such subgraph mining Baye-sian models. Thirdly, illustrate how chemogenomics, its particular flavor 'proteochemometrics', extrapolate predictions given points targets. Finally, extend concept 'chemoge-nomics' relating targets, into phenotypic space then falls area 'chemical genomics' genetics'; is very often desired endpoint not only pharmaceutical industry, but also academic probe discovery, experimental scientist most interested in. © 2011 Bentham Science Publishers.

参考文章(77)
Jordi Mestres, Computational chemogenomics approaches to systematic knowledge-based drug discovery. Current Opinion in Drug Discovery & Development. ,vol. 7, pp. 304- 313 ,(2004)
Alexis A Borisy, Andrew S Krueger, Grant R Zimmermann, Joseph Lehar, Therapeutic selectivity and the multi-node drug target. Discovery Medicine. ,vol. 8, pp. 185- ,(2009)
Hans Briem, Uta F. Lessel, In vitro and in silico affinity fingerprints: Finding similarities beyond structural classes Perspectives in Drug Discovery and Design. ,vol. 20, pp. 231- 244 ,(2000) , 10.1007/0-306-46883-2_13
Brent R. Stockwell, Chemical genetics: ligand-based discovery of gene function Nature Reviews Genetics. ,vol. 1, pp. 116- 125 ,(2000) , 10.1038/35038557
Anthony J Williams, Public chemical compound databases. Current Opinion in Drug Discovery & Development. ,vol. 11, pp. 393- 404 ,(2008) , 10.6084/M9.FIGSHARE.654769.V1
Gaia V Paolini, Richard H B Shapland, Willem P van Hoorn, Jonathan S Mason, Andrew L Hopkins, Global mapping of pharmacological space Nature Biotechnology. ,vol. 24, pp. 805- 815 ,(2006) , 10.1038/NBT1228
Jeroen Kazius, Ross McGuire, Roberta Bursi, Derivation and validation of toxicophores for mutagenicity prediction. Journal of Medicinal Chemistry. ,vol. 48, pp. 312- 320 ,(2005) , 10.1021/JM040835A
Andreas Bender, Robert C. Glen, A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication. Journal of Chemical Information and Modeling. ,vol. 45, pp. 1369- 1375 ,(2005) , 10.1021/CI0500177
Gerard J. P. van Westen, Jörg K. Wegner, Adriaan P. IJzerman, Herman W. T. van Vlijmen, A. Bender, Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets MedChemComm. ,vol. 2, pp. 16- 30 ,(2011) , 10.1039/C0MD00165A